Alliance Pharma PLC's (LON:APH) Peter Butterfield discusses with Proactive London's Andrew Scott the firm's interim results and says they delivered a solid first-half performance.
Revenues for the period were £70.3mln, up 28% on a constant currency basis, or an organic 10% if the impact of recent purchases was stripped out.